Search for articles
Single loading dose versus standard 24-hour magnesium sulfate in women with severe preeclampsia and eclampsia: A systematic review and metaanalysis
Dirdrah Aina Crisostomo Salvador, MD and Floriza Crisostomo Salvador, MD, FPOGS, FPSUOG
Department of Obstetrics and Gynecology, De La Salle University Hospital
Study Design: Metaanalysis and Systematic review of six randomized controlled trials
Patients/Subject Selection: Patients diagnosed with severe preeclampsia and eclampsia Intervention: Giving of single loading dose only (study group) versus 24-hour MgSO4 therapy (control) in patients with severe preeclampsia and eclampsia
Outcome Measures: (1) Anti-convulsant effects (2) Maternal: loss of deep tendon reflex and oliguria, incidences of caesarean section, Hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome, post partum hemorrhage and intensive care unit admissions and (3) Neonatal complications: incidences of neonatal intensive care unit (NICU) admission, APGAR score at 5 minutes and death
Results: Occurrence of seizures was similar in both groups. The risk difference of -0.00 (95% Confidence interval (CI): -0.04 to 0.03; p=0.84) showed no significant difference and the combined studies were found to be homogenous with an I2 of 0.0.
Conclusion: A single loading dose of MgSO4 is comparable in preventing seizures of preeclamptic and eclamptic patients with similar maternal and neonatal complications except for a lesser occurrence of decreased patellar reflex in the study group (p=<000001).